首页> 美国卫生研究院文献>BMJ Open >Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study
【2h】

Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study

机译:内型驱动的慢性阻塞性肺疾病急性加重预测(EndAECOPD):一项前瞻性队列研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current strategies for the prevention of acute exacerbations in chronic obstructive pulmonary disease (COPD) are primarily based on clinical measurements but fail to target the pathophysiological mechanisms, namely endotypes, of the disease. Studies identifying endotypes underlying exacerbation susceptibility and discovering specific biomarkers may lead to the development of targeted therapeutics but are lacking. This study aims to assess a broad spectrum of biomarkers at multiple biological levels (genetics, airway inflammation and respiratory microbiome) for their ability in predicting acute exacerbations of COPD, thus enables high-resolution disease endotyping and may lead to precision treatment of the disease.
机译:当前预防慢性阻塞性肺疾病(COPD)急性加重的策略主要基于临床测量,但未能针对该疾病的病理生理机制,即内型。鉴定加重易感性内在型并发现特定生物标志物的研究可能会导致靶向疗法的发展,但尚缺乏。这项研究旨在评估多种生物学水平(遗传学,气道炎症和呼吸微生物组)的生物标志物预测COPD急性加重的能力,从而实现高分辨率的疾病分型并可能导致疾病的精确治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号